March 14, 2018 Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin
August 3, 2018 Quantitative Approach for Cardiac Risk Assessment and Interpretation in Tuberculosis Drug Development
January 12, 2017 A Standardised Method for Interpreting the Association Between Mutations and Phenotypic Drug Resistance in Mycobacterium Tuberculosis
May 9, 2017 Two Arizona leaders in scientific collaboration partner to advance global TB research May 1, 2017 Two Arizona leaders in scientific collaboration partner to advance global TB research TUCSON and FLAGSTA
January 5, 2017 Tuberculosis and Antimicrobial Resistance – New Models of Research and Development Needed
May 1, 2017 Critical Path Institute and TGen Forge Partnership to Advance TB Research May 1, 2017 Critical Path Institute and TGen Forge Partnership to Advance TB Research TUCSON and FLAGSTAFF, May 1,
January 3, 2017 Removing the Bottleneck in Whole Genome Sequencing of Mycobacterium Tuberculosis for Rapid Drug Resistance Analysis: A Call to Action
